Hamid Borghei-Razavi, MD

Appointed
2019

Education & Fellowships

Fellowship - Cleveland Clinic
Advanced Open and Endoscopic Skull Base Surgery
Cleveland, OH USA
2019

Fellowship - Cleveland Clinic
Neurosurgical Oncology
Cleveland, OH USA
2018

Fellowship - University of Pittsburgh Medical Center
Surgical Neuroanatomy Research Fellow
Pittsburgh, PA USA
2017

Residency - Clemens hospital- University of Muenster
Neurological Surgery
Muenster, Germany
2015

Medical Education - Iran University of Medical Sciences
Tehran, Iran
2009

Additional Training

• Doctor of Medicine, University of Lübeck, Germany, 2014 
  

Professional Highlights

• Director of Minimally Invasive Cranial and Pituitary Surgery Program, Cleveland Clinic Florida
• Research director, Neuroscience Institute, Cleveland Clinic Florida Region 
• Assistant Professor of Neurological Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
• Associate program director, Skull Base Surgery Fellowship, Cleveland Clinic Florida
• Scientific Advisory Board member, Florida Center for Brain Tumor Research (FCBTR)
• Cranial Base Section Editor, World Neurosurgery Journal, Elsevier

Certifications

• Neurological Surgery
• Neurosurgery - Neurological Surgery

Specialty Interests

Minimally Invasive Brain Surgery, Pituitary and Skull Base Surgery, Trigeminal Neuralgia, Laser Interstitial Thermal Therapy (LITT) for Brain Tumors, Chiari Malformation

Awards & Honors

• Fellow of American College of Surgeons (FACS), 10/2023
• Scientific and Research Committee member, North American Skull Base Society (NASBS), 2022-2024
• Chair of Pituitary Education Day, North American Skull Base Society (NASBS), 2/2024
• Chair of Kawase Education Day, North American Skull Base Society (NASBS), 2/2023
• Scientific Advisory Board member, Florida Center for Brain Tumor Research (FCBTR), 05/2020
• KARL STORZ Endoscopy-America MIS Lab Grant, 02/2020
• Fellow of the European Board of Neurological Surgery (FEBNS), 03/2018
• Poster of Distinction Award; 27th Annual Meeting of North American Skull Base Society, New Orleans, Louisiana, 03/2017
• Rolf Dierichs Research Grant; Münster, Germany, 04/2014
• Karl-Storz Scholarship; German Soc. Skull Base Surgery, 10/2013
• Carls-Zeiss German-Japan Exchange Program Scholarship; German Soc. Neurosurgery & Dept. Neurosurgery and Skull Base Surgery, Keio University, Tokyo, Japan, 05/2013
• Karl-Storz Fellowship Award; 6th Intl. Congress of the World Federation of Skull Base Societies/10th European Skull Base Society Congress, Brighton, England, 05/2012

Memberships

• Congress of Neurological Surgeons (CNS)
• North American Skull Base Society (NASBS)
• American College of Surgeons (ACS)
• American Association of Neurological Surgery (Vascular and Tumor Section) (AANS)
• European Association of Neurological Surgery (EANS)
• German Society of Neurological Surgery (DGNC)

See publications for Hamid Borghei-Razavi, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/26/2023, Dr. Borghei-Razavi has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.